Latest news
MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:10 GMTMiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 16:11:24 GMT